Skip to content

Author

J. Bukowski

We have 1 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Abstract A020: Engineering developability of anti-CD3 scFv-based multispecific T-cell engagers

Stabilized anti-CD3 scFv not only improve properties of two clinical CD20 Fab-based multispecifics but rescue assembly of a third clinical CD20 molecule, which did not produce with the parental, unmodified scFv or with the industry standard engineered disulfide bond VH44-VK100.

Rob Pejchal, Kevin Schutz, Michael B. Battles et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.